nicotine has been researched along with fluorexon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coulibaly, SF; Linn, CL; Linn, DM; Thompson, SA; Wehrwein, E | 1 |
| Csoka, AB; Getachew, B; Khundmiri, SJ; Manavalan, S; Manaye, KF; McKinley, R; Reglodi, D; Tamas, A; Tizabi, Y | 1 |
2 other study(ies) available for nicotine and fluorexon
| Article | Year |
|---|---|
Acetylcholine protection of adult pig retinal ganglion cells from glutamate-induced excitotoxicity.
Topics: Acetylcholine; Animals; Bungarotoxins; Cell Separation; Cell Survival; Cells, Cultured; Choline; Cytoprotection; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Fluoresceins; Glutamic Acid; Neuroprotective Agents; Nicotine; Receptors, Nicotinic; Retinal Ganglion Cells; Swine | 2004 |
PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells: Implications for Drinking-Smoking Co-morbidity.
Topics: Calcium; Cell Line, Tumor; Cell Survival; Central Nervous System Depressants; Dose-Response Relationship, Drug; Drug Combinations; Ethanol; Fluoresceins; Humans; Neuroblastoma; Neurotransmitter Agents; Nicotine; Nicotinic Agonists; Pituitary Adenylate Cyclase-Activating Polypeptide | 2017 |